Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

Table 6 Summary of significant serum markers, by study

Ref.	NT-proBNP (pg/mL)	BNP (pg/mL)	Elevated albumin (mg/dL)	Elevated PTT (seconds)	Reduced INR	Reduced bilirubin (g/dL)
Alla et al[40]	720 [OR = 4.2 (2.3-9.5), P < 0.001]1
Billey et al[9]	> 125 (610 vs 206, P = 0.005)	BNP > 40 (368 vs 86, P = 0.001)
Modha et al[45]			5.2 vs 2.9, P = 0.028	15.0 vs 13.2, P = 0.029
Vanderschueren et al[41]	540 vs 150, HR = 1.04 (1.00-1.07)2		HR = 1.10 (1.03-1.18), P = 0.009
Wade et al[48]					1.18 vs 1.40 (P = 0.007)	1.02 vs 2.05 (P = 0.022)

¹Denotes median value.

²Adjusted for 100 ng/L increments.

NT-proBNP: N-terminal pro-B-type natriuretic peptide; BNP: B-type natriuretic peptide; PTT: Partial thromboplastin time; INR: International normalised ratio HR: Hazard ratio; OR: Odds ratio.